Researchers at Columbia Presbyterian Hospital are currently conducting a mesothelioma clinical trial in New York City to determine if a new experimental treatment for mesothelioma is effective and safe. Patients enrolled in this study will be administered three therapeutic drugs--cisplatin, pemetrexed, and bevacizumab-which will be used together to see if this new drug combination constitutes a more effective form of treatment than other standard therapies.
To be eligible for this mesothelioma clinical trial, prospective patients must not have undergone prior chemotherapy for the treatment of mesothelioma or have been treated with any of the drugs under the consideration of this study. Patients must also be willing to take B12 vitamin and folic acid supplements to participate in this mesothelioma clinical trial. New York City is the home of top cancer institutions such as Columbia Presbyterian Hospital. To learn more about this hospital and its cancer treatments, please click onthe following link: http://www.nyp.org/
To lean more about this new mesothelioma clinical trial designed to test the combination of Cisplatin, Pemetrexed, and Bevacizumab, please click on the following link: http://www.centerwatch.com/patient/studies/stu92726.html
Malignant Mesothelioma is a terminal form of cancer that arises primarily in the lining of the lungs and the abdomen; it is caused by the inhalation of asbestos. Generally speaking, mesothelioma takes at least fifteen years for symptoms to manifest themselves after a person's initial contact with asbestos. Even if a person is only exposed to asbestos for a short period of time, it is possible for them to develop mesothelioma in later life. Because asbestos fibers are microscopic, exposure can occur without an individual being aware of it.
Mesothelioma Attorneys at Levy Phillips & Konigsberg, LLP, have prosecuted mesothelioma claims in New York City, and throughout New York and New Jersey, for more than twenty-five years. LPK has offices in New York City and Lawrenceville, New Jersey and directly represents victims of asbestos-related diseases, including mesothelioma.
|
